Search - tctmd.com

Displaying 301 - 320 of 1355

Sort: Relevancy | Date

Presentation TVT 2022

Last Remaining Myocyte: Emergency ECMO and Staged PCI + TAVR

Presenter: Joseph Walsh

June 08, 2022

Presentation TVT 2022

Current and Future Standards for THV and Delivery System Platforms

Presenter: Rahul Sharma

June 08, 2022

Presentation TVT 2022

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Presenter: Ravi Ramana

June 08, 2022

Presentation TVT 2022

Total "Tandem" Approach for Cardiogenic Shock: TAVR and PCI

Presenter: Geoffrey Kunz

June 08, 2022

Presentation TVT 2022

Pushing the threshold: comparing aortic regurgitation outcomes to current guidelines and the possible need for earlier intervention

Presenter: Saif Anwaruddin

June 08, 2022

Presentation TVT 2022

The undertreatment of aortic regurgitation and understanding the need for surgical alternatives

Presenter: Vinod Thourani

June 08, 2022

Presentation TVT 2022

Cardiogenic Shock With Flash TAVR: The Importance of Event Sequencing

Presenter: Mark Bieniarz

June 08, 2022

Presentation TVT 2022

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Presenter: Martin Leon

June 08, 2022

Presentation TVT 2022

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Presenter: Philippe Genereux

June 08, 2022

Presentation TVT 2022

Moderate AS With Heart Failure: Updates and Lessons From TAVR UNLOAD

Presenter: Nicolas Van Mieghem

June 08, 2022

Presentation TVT 2022

Severe AS With No Symptoms: Updates From Surgical Trials, EARLY TAVR, and EVOLVE

Presenter: Mark Russo

June 08, 2022

Presentation TVT 2022

Post-Procedure; decreasing ICU footprint, accelerated discharge

Presenter: Tsuyoshi Kaneko

June 08, 2022

Presentation TVT 2022

Peri-Procedure segment; minimizing TAVR staff, TAVR step down unit

Presenter: Andrei Pop

June 08, 2022

Presentation TVT 2022

Pre-Procedure segment; efficiently working-up your TAVR patient

Presenter: Joseph Walsh

June 08, 2022

Presentation TVT 2022

Aortic Stenosis and lack of treatment during/post COVID-19, staffing issues and efficiency programs for TAVR optimization

Presenter: Vijay Iyer

June 08, 2022

Presentation TVT 2022

Flash Proposal: A Novel Bicuspid TAVR Trial in the Modern Era

Presenter: David Cohen

June 08, 2022

Presentation TVT 2022

Bicuspid TAVR Clinical Evidence: Data Takeaways and Evidence Gaps

Presenter: Steven Yakubov

June 08, 2022

Presentation TVT 2022

Explant Versus Redo TAVR After TAVR Failure: Outcomes From the EXPLANTORREDO-TAVR International Registry

Presenter: Syed Zaid

June 08, 2022

Presentation TVT 2022

Technical Pearls: Valve Choice, Sizing, and Positioning

Presenter: John K. Forrest

June 08, 2022

Presentation TVT 2022

When Is Surgery the First Choice?

Presenter: Mathew Williams

June 08, 2022

Advertisement

Last Remaining Myocyte: Emergency ECMO and Staged PCI + TAVR

Current and Future Standards for THV and Delivery System Platforms

Treating AR with TAVR: challenges, techniques, outcomes and a look at early real-world data with the Jenavalve Trilogy TAVR System

Total "Tandem" Approach for Cardiogenic Shock: TAVR and PCI

Pushing the threshold: comparing aortic regurgitation outcomes to current guidelines and the possible need for earlier intervention

The undertreatment of aortic regurgitation and understanding the need for surgical alternatives

Cardiogenic Shock With Flash TAVR: The Importance of Event Sequencing

Redefining the Future of Aortic Stenosis: Diagnosis, Classification, and Management

Moderate AS With Evidence of Cardiac Damage: The PROGRESS Trial

Moderate AS With Heart Failure: Updates and Lessons From TAVR UNLOAD

Severe AS With No Symptoms: Updates From Surgical Trials, EARLY TAVR, and EVOLVE

Post-Procedure; decreasing ICU footprint, accelerated discharge

Peri-Procedure segment; minimizing TAVR staff, TAVR step down unit

Pre-Procedure segment; efficiently working-up your TAVR patient

Aortic Stenosis and lack of treatment during/post COVID-19, staffing issues and efficiency programs for TAVR optimization

Flash Proposal: A Novel Bicuspid TAVR Trial in the Modern Era

Bicuspid TAVR Clinical Evidence: Data Takeaways and Evidence Gaps

Explant Versus Redo TAVR After TAVR Failure: Outcomes From the EXPLANTORREDO-TAVR International Registry

Technical Pearls: Valve Choice, Sizing, and Positioning

When Is Surgery the First Choice?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content